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Gut microbiota and nutrition: Where are we now?For the last ﬁfteen years, the place we give to our gut in patho-physiology has been profoundly
modiﬁed. The elucidation of the gut microbiome (bacterial genome) allowed to evaluate with a
different angle the role of the microbial ecosystem -composed of thousands of bacteria, but also of
viruses, phages, or moods-in the regulation of vital processes. We propose, in this special issue, to let
the ﬂoor to scientists and physicians considered as pioneers and experts in their respective area of
interest, to give an overview of the questions and answers arisen in different aspects of nutrition and
health upon the evaluation of nutrientsehostemicrobes interactions.
Microbial colonization of the gut occurs at birth, a phenomenon which is crucial for educating the
immune system. The paper written byM. Collado and collaborators [1] interestingly reports the role of
the nutritional status and diet of the microbiota shaping of the mother and the baby. The importance of
an adequate early colonization of microbiota might lead to update nutritional recommendations for
both mothers and babies in the management of diseases risks later in life.
Relating the gut microbiota to the immune systems allows to ask the question raised by L. Nylund
et al [2], on the role of gut microbiota in coeliac disease, as well as on and non-gluten coeliac sensitivity.
The authors point out the crucial role played by the gut microbiota on innate immune system edu-
cation and reactivity, and the difﬁculty to clearly elaborate a cause-effect relationship between speciﬁc
changes in gut microbes and the evolution of the disease.
The gut is now often presented as the “second brain”. For sure, this is due to the tremendous
innervation of the gastro-intestinal tract, that creates bottom-up and downstream neuronal networks
in the control of key functions, emotion, and stress behavior. One may not ignore anymore the role
played by the gut microbiota in the control of brain functions and behavior. The review of T. Dinan's
group and collaborators [3], points out the very interesting potential to develop novel therapeutic and
nutritional strategies to treat psychiatric disorders by targeting the gut microbiota.
A lot of hopes came from the discovery that the characteristics of human microbiome in obese or
diabetic could be considered as a way to envisage novel approaches of the metabolic disorders. The
paper proposed by Dao et al [4], mixing the experimental and clinical expertises of P. Cani and K.
Clement's groups, respectively, presents a summary of the nutritional and surgical intervention studies
in obese individuals, and points out the differences in response to treatment that can be attributed to
characteristics of the gut microbiome. This clearly supports the interest a new type of “personalized”
nutrition in this context. Similarly, J. Suez, H. Chapiro and E. Elinav [5] covered the ﬁeld of diabetes,
highlighting the way by which the gut microbiome controls glycemic response, thereby playing a role
in the management of type 1 and type 2 diabetes.http://dx.doi.org/10.1016/j.yclnex.2016.04.001
2352-9393/©2016TheAuthors. PublishedbyElsevier Ltdonbehalfof EuropeanSociety forClinicalNutrition andMetabolism. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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taken into account (including appropriate techniques) when trying to elaborate clinical studies
devoted to assess microbiomeehost interaction in metabolic diseases.
When talking about nutrition and health, one might often forget the fact that, upon evolution of
non-communicable diseases, undernutritionmay appear as an event precipitating the bad prognosis. It
is clearly the case of cachexia linked to cancer development. In this particular ﬁeld, the nutritional
advices could take into account the novel discoveries emostly related in animal models at this stage-
which allow to point out how dysbiosis and speciﬁc changes in the gut microbiota composition and
function, relates to muscle atrophia and related inﬂammation [6]. The nutritional support in oncology
would gain novel insights in view of those discoveries.
The patho-physiological contexts in which the gut microbiota is mentioned as a potential “partner”
or “target”, are expanding daily in view of the published papers relating the changes in gut microbiota
composition or function, associated with a health or disease status. In this special issue, we did not try
to cover all the ﬁelds in which the gut microbiota are probably playing a role, but we rather tried to
exemplify, that adequate nutrition must nowadays takes into account the bacterial ecosystem as a key
component of the digestive tract, playing a key role on energy, immune and behavioral homeostasis. All
the authors pointed out the need of a rationale methodological approaches in order to evaluate the role
of gut microbiota on host health in the next future.
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